Try it
Pathology · Neoplasia: viral oncogenesis
Sample itemA 35-year-old woman has CIN 3 with HPV 16 detected. Which HPV protein promotes carcinogenesis by binding p53 and targeting it for ubiquitin-mediated degradation?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. E6
In high-risk HPV types, E6 binds p53 with the ubiquitin ligase E6AP and causes its degradation, while E7 binds and inactivates Rb. Integration of viral DNA often disrupts E2, which normally represses E6 and E7, so their expression rises. L1 is the major capsid protein used in the vaccine.
Option by option
A. E6 (correct)
E6 degrades p53 through E6AP-mediated ubiquitination.
B. E2
E2 is a regulator that represses E6 and E7, and its loss on integration indirectly raises oncoprotein levels.
C. L1
L1 is the major capsid protein that forms the basis of the HPV vaccine and has no oncogenic action.
D. E7
E7 inactivates Rb and releases E2F, a separate mechanism from p53 degradation.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pathology questions
- HaematopathologyBinucleate 'owl-eye' cells that stain for CD15 and CD30 are characteristic of which cond…
- NeuropathologyEosinophilic intracytoplasmic inclusions in the pigmented neurons of the substantia nigr…
- HaemodynamicsWhich of the following is NOT a component of Virchow's triad for thrombosis?
- Granulomatous diseaseNon-caseating granulomas with Schaumann bodies and asteroid bodies are typical of: